Tangier Disease With Continuous Massive and Longitudinal Diffuse Calcification in the Coronary Arteries
2000; Lippincott Williams & Wilkins; Volume: 101; Issue: 20 Linguagem: Inglês
10.1161/01.cir.101.20.2446
ISSN1524-4539
AutoresRyutaro Komuro, Shizuya Yamashita, Satoru Sumitsuji, Ken‐ichi Hirano, Takao Maruyama, Makoto Nishida, Fumihiko Matsuura, Akifumi Matsuyama, Taizo Sugimoto, Noriyuki Ouchi, Naohiko Sakai, Tadashi Nakamura, Toru Funahashi, Yūji Matsuzawa,
Tópico(s)Atherosclerosis and Cardiovascular Diseases
ResumoHomeCirculationVol. 101, No. 20Tangier Disease With Continuous Massive and Longitudinal Diffuse Calcification in the Coronary Arteries Free AccessOtherPDF/EPUBAboutView PDFView EPUBSections ToolsAdd to favoritesDownload citationsTrack citationsPermissions ShareShare onFacebookTwitterLinked InMendeleyReddit Jump toFree AccessOtherPDF/EPUBTangier Disease With Continuous Massive and Longitudinal Diffuse Calcification in the Coronary Arteries Demonstration by the Sagittal Images of Intravascular Ultrasonography Ryutaro Komuro, Shizuya Yamashita, Satoru Sumitsuji, Ken-ichi Hirano, Takao Maruyama, Makoto Nishida, Fumihiko Matsuura, Akifumi Matsuyama, Taizo Sugimoto, Noriyuki Ouchi, Naohiko Sakai, Tadashi Nakamura, Toru Funahashi and Yuji Matsuzawa Ryutaro KomuroRyutaro Komuro From the Department of Internal Medicine and Molecular Science, Graduate School of Medicine, Osaka University, Osaka, Japan. , Shizuya YamashitaShizuya Yamashita From the Department of Internal Medicine and Molecular Science, Graduate School of Medicine, Osaka University, Osaka, Japan. , Satoru SumitsujiSatoru Sumitsuji From the Department of Internal Medicine and Molecular Science, Graduate School of Medicine, Osaka University, Osaka, Japan. , Ken-ichi HiranoKen-ichi Hirano From the Department of Internal Medicine and Molecular Science, Graduate School of Medicine, Osaka University, Osaka, Japan. , Takao MaruyamaTakao Maruyama From the Department of Internal Medicine and Molecular Science, Graduate School of Medicine, Osaka University, Osaka, Japan. , Makoto NishidaMakoto Nishida From the Department of Internal Medicine and Molecular Science, Graduate School of Medicine, Osaka University, Osaka, Japan. , Fumihiko MatsuuraFumihiko Matsuura From the Department of Internal Medicine and Molecular Science, Graduate School of Medicine, Osaka University, Osaka, Japan. , Akifumi MatsuyamaAkifumi Matsuyama From the Department of Internal Medicine and Molecular Science, Graduate School of Medicine, Osaka University, Osaka, Japan. , Taizo SugimotoTaizo Sugimoto From the Department of Internal Medicine and Molecular Science, Graduate School of Medicine, Osaka University, Osaka, Japan. , Noriyuki OuchiNoriyuki Ouchi From the Department of Internal Medicine and Molecular Science, Graduate School of Medicine, Osaka University, Osaka, Japan. , Naohiko SakaiNaohiko Sakai From the Department of Internal Medicine and Molecular Science, Graduate School of Medicine, Osaka University, Osaka, Japan. , Tadashi NakamuraTadashi Nakamura From the Department of Internal Medicine and Molecular Science, Graduate School of Medicine, Osaka University, Osaka, Japan. , Toru FunahashiToru Funahashi From the Department of Internal Medicine and Molecular Science, Graduate School of Medicine, Osaka University, Osaka, Japan. and Yuji MatsuzawaYuji Matsuzawa From the Department of Internal Medicine and Molecular Science, Graduate School of Medicine, Osaka University, Osaka, Japan. Originally published23 May 2000https://doi.org/10.1161/01.CIR.101.20.2446Circulation. 2000;101:2446–2448A 48-year-old man was first referred to our clinic in January 1989 because of marked hypocholesterolemia with very low HDL cholesterol, anemia, and hyperbilirubinemia. He had large tonsils, corneal opacities, hepatosplenomegaly, and thrombocytopenia. Serum levels of total cholesterol, triglycerides, and HDL cholesterol were 0.72, 2.6, and 0.16 mmol/L (28, 232, and 6 mg/dL), respectively. Concentrations of apolipoproteins (apo) A-I and A-II were 1.3 and 0.9 μmol/L (3.9 and 1.5 mg/dL), respectively. His daughter's serum levels of total cholesterol, HDL cholesterol, and apo A-I were 3.3 mmol/L, 0.64 mmol/L, and 34.7 μmol/L (128, 24, and 104 mg/dL), respectively. He was diagnosed with Tangier disease by clinical manifestations, analysis of lipoproteins, and 2D electrophoresis, which confirmed the increase of preproapo A-I. Interestingly, xanthoma in the Achilles' tendons, which had rarely been reported in patients with Tangier disease, was observed in the patient, and the thickness was 9 mm (mean of bilateral determinations; control, 6±2 mm). Subsequently, the diagnosis of homozygous Tangier disease was also established by biopsy of the patient's bone marrow, showing the presence of foam cells (Figure 1).Our patient began having exertional chest pain in January 1997. Myocardial perfusion images with 201Tl revealed a defect in the inferoposterior wall with an incomplete redistribution; thus, a coronary angiogram was performed in July 1997. It revealed massive and longitudinal diffuse calcifications in the 3 coronary arteries that could be seen only on the scout radiograph (Figure 2A and 2C). We also found severe atherosclerosis in all 3 vessels, including the left main trunk (LMT); 90% stenosis in the mid portion of the right coronary artery (RCA) (segment 2), 75% stenosis in the LMT (segment 5), 75% stenosis in the proximal portion of the left anterior descending coronary artery (LAD) (segment 6), 75% stenosis in the mid portion of the LAD (segment 7), 90% stenosis in the just proximal portion of the left circumflex artery (LCx) (segment 11), and 90% stenosis in the mid portion of the LCx (segment 13), respectively (Figures 2B, 2D, and 3).We performed intravascular ultrasonography (IVUS) simultaneously with the coronary angiogram, and it demonstrated notably that the atherosclerotic plaque with intimal thickening and its superficial calcification protruded toward the center of the lumen in cross-sectional IVUS images (Figure 3, I and II). Conversely, only a very thin plaque was observed on the opposite side of the protrusion (Figure 3, I and II). Consequently, the lumen there, especially in II, appeared crescent-shaped (Figure 3, red trace). We then obtained different sagittal sections of 3D-reconstructed IVUS images to analyze the coronary arteries more precisely. It was also noteworthy that massive and longitudinal diffuse calcifications extended continuously from distal to the second diagonal branch to the LMT (Figure 3, bottom right, white arrows). The editor of Images in Cardiovascular Medicine is Hugh A. McAllister, Jr, MD, Chief, Department of Pathology, St Luke's Episcopal Hospital and Texas Heart Institute, and Clinical Professor of Pathology, University of Texas Medical School and Baylor College of Medicine.Circulation encourages readers to submit cardiovascular images to the Circulation Editorial Office, St Luke's Episcopal Hospital and Texas Heart Institute, 6720 Bertner Ave, MC1-267, Houston, TX 77030.Download figureDownload PowerPoint Figure 1. Puncture sample of bone marrow stained with Sudan III and analyzed by light microscopy shows foam cells with accumulated lipid droplets (arrow). Bar=10 μm.Download figureDownload PowerPoint Figure 2. Coronary angiogram. A and B, Left anterior oblique projections of right coronary artery. C and D, Right anterior oblique caudal projections of left coronary artery. Arrows indicate longitudinal and massive diffuse calcifications of coronary arteries in scout films (A and C). In RCA, 90% stenosis was observed in mid portion (B). Significant stenosis is also shown in proximal and mid portions of LAD and in proximal and mid portions of left circumflex artery (D). Moreover, 75% stenosis is seen in left main trunk (D).Download figureDownload PowerPoint Figure 3. Coronary angiogram (left anterior oblique cranial projections) and IVUS images of LAD. Black arrows indicate longitudinal and massive diffuse calcifications in scout films (top left). Left circumflex artery and first diagonal branch (D1) are shown in 4 o'clock position in cross-sectional IVUS images (top right, I and II). Both cross-sectional IVUS images, especially II, demonstrate atherosclerotic plaque with intimal thickening and its superficial protruded calcification in 2 o'clock position. Only a very thin plaque is seen on opposite side. Lumen there, especially in II, appears crescent-shaped (red trace). Differential sagittal sections of IVUS images 3D-reconstructed by NetraIVUS (Scimage Inc) (bottom right) demonstrated massive and longitudinal diffuse calcifications extending continuously from distal to second diagonal branch (D2) to left main trunk (bottom right, white arrows).FootnotesCorrespondence to Ken-ichi Hirano, MD, PhD, Department of Internal Medicine and Molecular Science, Graduate School of Medicine, B5, Osaka University, 2–2, Yamadaoka, Suita, Osaka 565-0871, Japan. E-mail [email protected] Previous Back to top Next FiguresReferencesRelatedDetailsCited By Koseki M, Yamashita S, Ogura M, Ishigaki Y, Ono K, Tsukamoto K, Hori M, Matsuki K, Yokoyama S and Harada-Shiba M (2021) Current Diagnosis and Management of Tangier Disease, Journal of Atherosclerosis and Thrombosis, 10.5551/jat.RV17053, 28:8, (802-810), Online publication date: 1-Aug-2021. Yamashita S and Matsuzawa Y (2018) Low HDL and High HDL Syndromes Encyclopedia of Endocrine Diseases, 10.1016/B978-0-12-801238-3.04000-9, (327-339), . Muratsu J, Koseki M, Masuda D, Yasuga Y, Tomoyama S, Ataka K, Yagi Y, Nakagawa A, Hamada H, Fujita S, Hattori H, Ohama T, Nishida M, Hiraoka H, Matsuzawa Y and Yamashita S (2018) Accelerated Atherogenicity in Tangier Disease, Journal of Atherosclerosis and Thrombosis, 10.5551/jat.43257, 25:10, (1076-1085), Online publication date: 1-Oct-2018. Brunham L and Hayden M (2015) Human genetics of HDL: Insight into particle metabolism and function, Progress in Lipid Research, 10.1016/j.plipres.2015.01.001, 58, (14-25), Online publication date: 1-Apr-2015. Koseki M, Matsuyama A, Nakatani K, Inagaki M, Nakaoka H, Kawase R, Yuasa-Kawase M, Tsubakio-Yamamoto K, Masuda D, C. Sandoval J, Ohama T, Nakagawa-Toyama Y, Matsuura F, Nishida M, Ishigami M, Hirano K, Sakane N, Kumon Y, Suehiro T, Nakamura T, Shimomura I and Yamashita S (2009) Impaired Insulin Secretion in Four Tangier Disease Patients with ABCA1 Mutations, Journal of Atherosclerosis and Thrombosis, 10.5551/jat.E599, 16:3, (292-296), . Matsuura F, Hirano K, Ikegami C, Sandoval J, Oku H, Yuasa-Kawase M, Tsubakio-Yamamoto K, Koseki M, Masuda D, Tsujii K, Ishigami M, Nishida M, Shimomura I, Hori M and Yamashita S (2007) Senescent phenotypes of skin fibroblasts from patients with Tangier disease, Biochemical and Biophysical Research Communications, 10.1016/j.bbrc.2007.03.172, 357:2, (493-498), Online publication date: 1-Jun-2007. (2008) References Color Atlas of Local and Systemic Signs of Cardiovascular Disease, 10.1002/9780470692424.refs, (103-109) Ohama T, Hirano K, Zhang Z, Aoki R, Tsujii K, Nakagawa-Toyama Y, Tsukamoto K, Ikegami C, Matsuyama A, Ishigami M, Sakai N, Hiraoka H, Ueda K, Yamashita S and Matsuzawa Y (2002) Dominant expression of ATP-binding cassette transporter-1 on basolateral surface of Caco-2 cells stimulated by LXR/RXR ligands, Biochemical and Biophysical Research Communications, 10.1016/S0006-291X(02)00853-7, 296:3, (625-630), Online publication date: 1-Aug-2002. Takami H, Kobayashi T, Nakagawa T, Sakurai M, Awata N and Yamashita S (2002) Coronary artery bypass grafting for a patient with Tangier disease, The Japanese Journal of Thoracic and Cardiovascular Surgery, 10.1007/BF02913190, 50:9, (383-386), Online publication date: 1-Sep-2002. Nishida Y, Hirano K, Tsukamoto K, Nagano M, Ikegami C, Roomp K, Ishihara M, Sakane N, Zhang Z, Tsujii K, Matsuyama A, Ohama T, Matsuura F, Ishigami M, Sakai N, Hiraoka H, Hattori H, Wellington C, Yoshida Y, Misugi S, Hayden M, Egashira T, Yamashita S and Matsuzawa Y (2002) Expression and Functional Analyses of Novel Mutations of ATP-Binding Cassette Transporter-1 in Japanese Patients with High-Density Lipoprotein Deficiency, Biochemical and Biophysical Research Communications, 10.1006/bbrc.2001.6219, 290:2, (713-721), Online publication date: 1-Jan-2002. Tsukamoto K, Hirano K, Tsujii K, Ikegami C, Zhongyan Z, Nishida Y, Ohama T, Matsuura F, Yamashita S and Matsuzawa Y (2001) ATP-Binding Cassette Transporter-1 Induces Rearrangement of Actin Cytoskeletons Possibly through Cdc42/N-WASP, Biochemical and Biophysical Research Communications, 10.1006/bbrc.2001.5575, 287:3, (757-765), Online publication date: 1-Sep-2001. Hirano K, Matsuura F, Tsukamoto K, Zhang Z, Matsuyama A, Takaishi K, Komuro R, Suehiro T, Yamashita S, Takai Y and Matsuzawa Y (2000) Decreased expression of a member of the Rho GTPase family, Cdc42Hs, in cells from Tangier disease - the small G protein may play a role in cholesterol efflux, FEBS Letters, 10.1016/S0014-5793(00)02171-2, 484:3, (275-279), Online publication date: 10-Nov-2000. May 23, 2000Vol 101, Issue 20 Advertisement Article InformationMetrics Copyright © 2000 by American Heart Associationhttps://doi.org/10.1161/01.CIR.101.20.2446 Originally publishedMay 23, 2000 PDF download Advertisement
Referência(s)